Case Report: Recurrent uterine inflammatory myofibroblastic tumor harboring IGFBP5-ALK fusion with sustained response to iruplinalkib - Top-Institutions - MDSpire

Case Report: Recurrent uterine inflammatory myofibroblastic tumor harboring IGFBP5-ALK fusion with sustained response to iruplinalkib

By
Ke Zhao
Min Hu
Runfeng Yang
Yi Huang
June 12, 2026
0 min

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

our hospital

Unknown, Unknown
Key Differentiators
- Oncology
#2

Burning Rock

Unknown, Unknown
Key Differentiators
- Oncology
#3

outside institution

Unknown, Unknown
Key Differentiators
- Oncology
#4

National Cancer Institute

Bethesda, MD
Key Differentiators
- Oncology
#5

The University of Texas MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Oncology